Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 333

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 8
Chunk 333
---
.11 %1,074 4.11 %1,074 5.35% senior notes due 20445.39 %750 — — 4.70% senior notes due 20454.73 %2,700 4.73 %2,700 4.75% senior notes due 20454.20 %881 4.20 %881 4.45% senior notes due 20464.50 %2,000 4.50 %2,000 4.875% senior notes due 20484.94 %1,750 4.94 %1,750 4.25% senior notes due 20494.29 %5,750 4.29 %5,750 5.40% senior notes due 20545.44 %3,000 — — 5.50% senior notes due 20645.53 %1,500 — — Fair value hedges(224)(266)Unamortized bond discounts(130)(106)Unamortized deferred financing costs(266)(198)Unamortized bond premiums555 668 Financing liability328 — Other40 42 Total long-term debt and finance lease obligations67,144 59,385 Current portion6,804 7,191 Noncurrent portion$60,340 $52,194 (a)Excludes the effect of any related interest rate swaps.

75     |  2024 Form 10-K

Senior notes and floating rate term loans are redeemable prior to maturity at a redemption price equal to the principal amount plus a make-whole premium and AbbVie may redeem these debt securities at par generally between one and six months prior to maturity. At December 31, 2024, the company was in compliance with its senior note covenants and term loan covenants. Maturities of Long-Term Debtas of and for the years ending December 31 (in millions)2025$6,771 20266,000 20275,028 20283,047 20298,570 Thereafter37,425 Total obligations and commitments66,841 Fair value hedges, unamortized bond premiums/discounts, deferred financing costs, finance lease obligations and financing liability303 Total long-term debt and finance lease obligations$67,144 Financing Related